Session M: Evolving technologies and viral hepatitis care
Tracks
Track 1
Tuesday, May 31, 2022 |
11:30 AM - 1:00 PM |
Ballroom 2 |
Speaker
Dr Kathy Jackson
Principal Scientist
Victorian Infectious Diseases Reference Laboratory
Hepatitis B: Evaluation of current and new diagnostic biomarkers
11:30 AM - 11:45 AMBiography
Dr Kathy Jackson is the Principal Scientist at VIDRL, at the Doherty Institute. She has extensive experience with diagnosis of hepatitis viruses and is Director of a WHO Regional Reference Laboratory for Hepatitis B/D in the Western Pacific Region. Kathy has a particular interest in use of point of care tests and simplifying testing for viral hepatitis.
Jordan Feld
Physician
University of Toronto/Liver Centre for Liver Disease
Advances in HCV diagnostics
11:46 AM - 12:01 PMBiography
Dr. Feld trained in GI and Hepatology at the University of Toronto and did post-doctoral training in the Liver Diseases Branch at the National Institutes of Health in laboratory and clinical research in viral hepatitis. After completing a Masters in Public Health at the Johns Hopkins Bloomberg School of Public Health, he returned to Toronto. He is a Professor of Medicine at the University of Toronto and holds the R. Phelan Chair in Translational Liver Research as a clinician-scientist at the Toronto Centre for Liver Disease in the Toronto General Hospital where he leads a large clinical and translational research program focused primarily on viral hepatitis and its complications.
Associate Professor Jessica Howell
Hepatologist And Senior Research Fellow
St Vincent's Hospital Melbourne
Advances in diagnostic testing for liver disease and HCC
12:02 PM - 12:17 PMBiography
Assoc Prof Jessica Howell MBBS(Hons) FRACP PhD MSc (Epi) PGDip PH is a gastroenterologist and senior research fellow in the Department of Gastroenterology, St Vincent’s Hospital Melbourne/ University of Melbourne and leads the Hepatitis B research group within the Disease Elimination program at Burnet Institute.
Prof Mark Stoove
Discipline Head
Burnet Institute
Imagining the unimaginable: What could the future hold for new technologies and viral hepatitis care?
12:18 PM - 12:33 PMBiography
Mark Stoove is head of the Public Health Discipline at the Burnet Institute and leads research groups in HIV Prevention and Justice Health. He is an infectious diseases and behavioural epidemiologist and implementation scientist and has researched the transmission and prevention blood borne virus and sexually transmitted infection for over 20 years.
Chair
Joe Doyle
Deputy Program Director, Disease Elimination
Burnet Institute
Rosemary Gilliver
Clinical Nurse Consultant
Kirketon Road Centre
Staff
Jeremy Cott
Senior Event Coordinator
ASHM Health
Sam Williamson
Senior Event Manager
Ashm
TP Operator
Karen Armstrong
Touchpoint
Touchpoint 3 Tablet
Touchpoint 4 Tablet
Erica Zarins
Touchpoint
